Table 3 Postoperative complications and survival
Paper | Subgroup | n | Bleeding complications (%) | Thromboembolic complications (%) | Favorable functional outcomes (%) | Length of hospitalization (days) | Mortality (%) |
|---|---|---|---|---|---|---|---|
Beynon | Overall | 21 | 1 (4.8%) | 0 | – | – | 1 (4.8%) |
Ellenberger | High bleeders | 39 | – | – | – | 31 (79.5%) | 14 (35.9%) |
Low bleeders | 53 | – | – | – | 23.5 (44.3%) | 11 (20.8%) | |
Li | TEG | 93 | 5 (5.38%) | 21 (22.6%) | 89 (95.7%) | – | – |
Control | 52 | 6 (11.5%) | 15 (28.8%) | 50 (96.2%) | – | – | |
Majmundar | VerifyNow | 208 | 39 (18.8%) | – | – | – | – |
Control | 137 | 22 (16.1%) | – | – | – | – | |
Rimaitis | ROTEM | 69 | 31 (44.9%) | – | 32 (46.4%) | 17 (24.6%) | 18 (26.1%) |
Control | 65 | 21 32.3%) | Â | 23 (35.4%) | 22 (33.8%) | 2 (3.1%) | |
Vahtera | ROTEM | 17 | – | – | 14 (82.4%) | – | 1 (5.9%) |
Control | 16 | – | – | – | – | – | |
Von der Brelie | Impaired platelet function | 55 | 5 (9.0%) | – | 17 (30.9%) | – | 17 (21.5%) |
Normal platelet function | 24 | 2 (8.3%) | – | 8 (33.3%) | – |  |